The AutoKVO™ KIT incorporates the Go Medical Springfusor® Syringe Infusion Pump and Flow Control Tubing (FCT) 

SpringFusor, a simple reusable spring-driver pump used for continuous IV infusions over time, requires no batteries or electricity. The pump is matched with various special sized tubing to determine actual flow rate.

 

Features:

  • 24-Hour Flow Rate (10ml, .3ml/minute)

  • Compact and very portable

  • Reusable

  • No programming required

  • Not gravity dependent

  • Once-daily replacement of pre-filled saline solution is all that is required.

KVO Springfusor®, 10ml

An exclusive model to be modified to accept a 10 mL Pre-filled Saline Flush Syringe (B-D / MonoJect) and companion Flow Control Tubing (FCT) with Y-Site needle-free injection site for Intermittent Drug Delivery.

Maintaining positive pressure in the catheter avoids reflux and clotting of blood (Catheter Occlusion), which can lead to infections and complications that may cause re-hospitalization.

The goal is early departure from the hospital setting to the patients’ home or other lower cost skilled nursing facility.

Section 5012 of the 21st Century Cures Act

On December 13, 2016, the 21st Century Cures Act (the Cures Act) was enacted into law. Section 5012 of this new law amended sections 1861(s)(2) and 1861(iii) of the Act, and established a new Medicare home infusion therapy benefit. The Medicare home infusion therapy benefit is for coverage of home infusion therapy-associated professional services for certain drugs and biologicals administered intravenously, or subcutaneously through a pump that is an item of DME, effective January 1, 2021. Section 1861(iii)(2) of the Act defines home infusion therapy to include the following items and services: the professional services (including nursing services), furnished in accordance with the plan, training, and education (not otherwise included in the payment for the DME), remote monitoring, and other monitoring services for the provision of home infusion therapy furnished by a qualified home infusion therapy supplier in the patient’s home.

The Acute Hospital Care at Home program is an expansion of the CMS Hospital Without Walls initiative launched in March 2020 as a part of a comprehensive effort to increase hospital capacity, maximize resources, and combat COVID-19 to keep Americans safe. This program creates additional flexibility that allows for certain health care services to be provided outside of a traditional hospital setting and within a patient’s home.

Updates to the Home Infusion Therapy Benefit for CY 2022

CMS is updating the home infusion therapy services payment rates for CY 2022 as required by law. In addition, CMS is updating the geographic adjustment factor used for wage adjustment and to maintain the percentages finalized in the CY 2020 Home Health PPS final rule with comment period for the initial and subsequent visit payment policy. The overall economic impact of updating the payment rates for home infusion therapy services is expected to be an increase in payments to home infusion therapy suppliers of 5.1 percent, based on the percentage increase in the consumer price index for all urban consumers (CPI-U) reduced by the productivity adjustment for CY 2022.  The CPI-U for the 12-month period ending in June of 2021 is 5.4 percent and the corresponding productivity adjustment is 0.3 percent.

Optionally CMS Waivers will allow participating hospitals to directly service patients in their homes with or without the usual 3 Day Hospital Stay. In addition, the global DRG will be a funding source eliminating the need for costly and time-consuming reimbursement obstacles such as coding and billings. This means that funds can be used at the discretion of the hospital to achieve the best outcome at the lowest cost without reimbursement issues. This allows the use of cost-effective devices and new technology at the discretion of the hospital and physicians.

Device to be assembled in Buffalo from Australian components. Components are 510K Approved by the FDA. Our group controls distribution rights. Currently, there are 2.7 million PICC catheter placements per year, a growing number of which are midline catheters.

 

1083 Delaware Avenue, Buffalo, New York 14209

Kevin@ShannonGroup.biz | (716) 563-1781